2006 Fiscal Year Final Research Report Summary
Basic Research of Gene Therapy for Intractable Pain with siRNA
Project/Area Number |
17591630
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Anesthesiology/Resuscitation studies
|
Research Institution | Okayama University |
Principal Investigator |
YOKOYAMA Masataka Graduate School of Medicine, Dentistry & Pharmaceutical Sciences, Associate professor, 大学院医歯薬学総合研究科, 助教授 (20158380)
|
Co-Investigator(Kenkyū-buntansha) |
ITANO Yoshitaro Graduate School of Medicine, Dentistry & Pharmaceutical Sciences, Research Associate, 大学院医歯薬学総合研究科, 助手 (30127542)
MIZOBUCHI Satoshi University Hospital of Medicine & Dentistry, Lecturer, 医学部・歯学部附属病院, 講師 (70311800)
MORITA Kiyoshi Graduate School of Medicine, Dentistry & Pharmaceutical Sciences, Professor, 大学院医歯薬学総合研究科, 教授 (40108171)
|
Project Period (FY) |
2005 – 2006
|
Keywords | Intractable Pain / siRNA / Gene Therapy / BDNF |
Research Abstract |
To investigate which exon of BDNF is involved in inflammatory pain, we quantitated infIammation-induced expression of BDNF exons in the rat DRG. Rats received subcutaneous injections of complete Freund's adjuvant (CFA) into plantar surface of the left hind paw. InCFA-treated rats, the expressions of exon I in ipsilateral DRGincreased significantly. Our results support that inflammation increases total BDNF mRNA. Furthermore, our results indicate that exon I plays important role in increase in BDNF mRNA after inflammation. Therefore, we targeted the exon I of BDNF for knock-down with siRNA. We created the two different siRNAs for exson I of BDNF. The intrathecal catheter was inserted 10 days before CFA injection. The two different siRNAs for the exon I of BDNF twice before CFA injection. The pain behaviors were decreased by the administration of siRNAs, but not completed suppressed. The expression of BDNF was not completed suppressed in DRG after the administration of the two siRNAs. In the future, We have to investigate how much doses of siRNA should be administered. We also have to check the timing when siRNA should be administerd.
|
-
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Update on opioid.2005
Author(s)
Ishikawa S, Mizobuchi S, Nishie H, Matsusaki T, Fujii M, Abo K, Sato K, Nakatsuka H, Matsumi M, Yokoyama M, Morita K.
-
Journal Title
The Journal of Palliative Medicine 12
Pages: 41-6
Description
「研究成果報告書概要(欧文)」より